| Literature DB >> 31837385 |
Thonnie Rose O See1, Gustav Stålhammar2, Tina Tang3, Joshua S Manusow3, David R Jordan3, Jeffrey A Nerad4, Robert C Kersten5, Marc Yonkers6, Nasreen A Syed7, Seymour Brownstein3, Hans E Grossniklaus8.
Abstract
Primary ductal adenocarcinoma (PDA) is a rare epithelial tumor of the lacrimal gland. Herein we report 5 cases and review 29 published cases of PDA of the lacrimal gland. Among these 5 cases, the most common clinical presentation was painless swelling and/or proptosis of their eye. The size of the lesions ranged from 1.6 to 2.5 cm. Histopathologic examination revealed proliferations of ductal or gland-like cells with vesiculated pleomorphic nuclei and prominent nucleoli. Tumor cells stained positive for epithelial and apocrine differentiation markers. Immunohistochemistry for human epidermal growth factor 2 was positive in 2 of the 4 cases. Four of the five patients were alive at the last follow-up visit. One died with bone metastases, which were diagnosed 25 months after exenteration and then survived an additional 51 months. On reviewing of twenty-nine previously published cases of PDA, the mean age of diagnosis was 58 years, with a male predominance (75%). Fifteen patients (54%) had distant metastases, 1 (4%) had local recurrence, and 10 (37%) suffered from a PDA-related death. PDA is a high-grade aggressive epithelial tumor of the lacrimal gland. Although rare, awareness and recognition of this malignancy are important to help determine prognosis and treatment options.Entities:
Keywords: immunohistochemistry; lacrimal gland; metastases; primary ductal adenocarcinoma
Mesh:
Substances:
Year: 2019 PMID: 31837385 PMCID: PMC7215120 DOI: 10.1016/j.survophthal.2019.11.002
Source DB: PubMed Journal: Surv Ophthalmol ISSN: 0039-6257 Impact factor: 6.048